| RS527236108 |
RPGR
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Thyroid cancer |
| RS527236109 |
RPGR
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS527236111 |
RPGR
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS527236112 |
RPGR
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, RPGR-related retinopathy |
| RS527236113 |
SNRNP200
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS527236114 |
SNRNP200
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS527236115 |
SNRNP200
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinal dystrophy |
| RS527236116 |
TOPORS
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS527236117 |
TULP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa 14 |
| RS527236118 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS527236120 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS527236121 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS527236122 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Usher syndrome type 2A |
| RS527236123 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS527236124 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS527236125 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS527236126 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Leber congenital amaurosis |
| RS527236127 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS527236129 |
ABCA4
|
Health Risk |
Pathogenic |
Severe early-childhood-onset retinal dystrophy, Severe early-childhood-onset retinal dystrophy |
| RS527236131 |
ADGRV1
|
Health Risk |
Pathogenic |
Usher syndrome type 2C, Usher syndrome type 2C |
| RS527236132 |
ADGRV1
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2C, Usher syndrome type 2C |
| RS527236133 |
ADGRV1
|
Health Risk |
Pathogenic |
Usher syndrome type 2C, Rare genetic deafness |
| RS527236134 |
MERTK
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 38, Retinitis pigmentosa 38 |
| RS527236135 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS527236136 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS527236137 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Rare genetic deafness |
| RS527236138 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS527236139 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2A, Retinitis pigmentosa |
| RS527236145 |
COL2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Connective tissue disorder, Connective tissue disorder |
| RS527236146 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS527236147 |
PYGM
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type V |
| RS527236148 |
SCN4A
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypokalemic periodic paralysis, type 2 |
| RS527236149 |
SCN4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypokalemic periodic paralysis, type 2 |
| RS527236150 |
SCN4A
|
Health Risk |
Pathogenic |
Hypokalemic periodic paralysis, type 2 |
| RS527236153 |
KCNJ18
|
Health Risk |
risk factor |
Thyrotoxic periodic paralysis, susceptibility to |
| RS527236158 |
KCNJ18
|
Health Risk |
risk factor |
Thyrotoxic periodic paralysis, susceptibility to |
| RS527236159 |
KCNJ18
|
Health Risk |
risk factor |
Thyrotoxic periodic paralysis, susceptibility to |
| RS527236212 |
SPRTN
|
Health Risk |
Pathogenic |
Progeroid features-hepatocellular carcinoma predisposition syndrome, Progeroid features-hepatocellular carcinoma predisposition syndrome |
| RS527236213 |
SPRTN
|
Health Risk |
Pathogenic |
Progeroid features-hepatocellular carcinoma predisposition syndrome, Progeroid features-hepatocellular carcinoma predisposition syndrome |
| RS527236214 |
-
|
Health Risk |
Pathogenic |
— |
| RS527236952 |
COL6A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Inborn genetic diseases |
| RS527241870 |
GUCA1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS527246699 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS527248111 |
NOTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adams-Oliver syndrome 5, Adams-Oliver syndrome 5 |
| RS527250558 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS527255616 |
EVC
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS527265374 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS527267420 |
LPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS527271139 |
FOXC1
|
Health Risk |
Pathogenic |
Axenfeld-Rieger syndrome type 3, Axenfeld-Rieger syndrome type 3 |
| RS527286038 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS527286367 |
ST3GAL5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS527291598 |
COL3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Ehlers-Danlos syndrome |
| RS527291754 |
BLM
|
Health Risk |
Conflicting classifications of pathogenicity |
Bloom syndrome, Hereditary cancer-predisposing syndrome |
| RS527295360 |
EFHC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Seizure, Myoclonic epilepsy |
| RS527297896 |
GFI1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Platelet-type bleeding disorder 17, Platelet-type bleeding disorder 17 |
| RS527302772 |
FSIP2
|
Health Risk |
Pathogenic |
Spermatogenic failure 34, Spermatogenic failure 34 |
| RS527315265 |
NTHL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 3 |
| RS527315924 |
TRMU
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS527322470 |
ANO5
|
Health Risk |
Conflicting classifications of pathogenicity |
Gnathodiaphyseal dysplasia, Autosomal recessive limb-girdle muscular dystrophy type 2L |
| RS527336882 |
IDUA
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS527346259 |
KIF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 30, Intellectual disability |
| RS527356550 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome, Kabuki syndrome 1 |
| RS527358320 |
COL1A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Infantile cortical hyperostosis, Osteogenesis imperfecta |
| RS527361141 |
RBP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS527372531 |
CSPP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 21, Joubert syndrome 21 |
| RS527383658 |
VPS13C
|
Health Risk |
Pathogenic |
— |
| RS527384137 |
SCN4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypokalemic periodic paralysis, type 2 |
| RS527387894 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS527394446 |
SETX
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Spinocerebellar ataxia |
| RS527404915 |
MYO15A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS527410720 |
HNRNPU
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 54 |
| RS527412689 |
DNM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 31A |
| RS527414180 |
AARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Inborn genetic diseases |
| RS527416146 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS527416373 |
HSPG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Schwartz-Jampel syndrome type 1, Schwartz-Jampel syndrome type 1 |
| RS527418139 |
VPS13A
|
Health Risk |
Conflicting classifications of pathogenicity |
Chorea-acanthocytosis, Chorea-acanthocytosis |
| RS527420845 |
JAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alagille syndrome due to a JAG1 point mutation, Tetralogy of Fallot |
| RS527421775 |
FA2H
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 35, Spastic paraplegia |
| RS527433112 |
COL5A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Connective tissue disorder, Ehlers-Danlos syndrome |
| RS527433244 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
BAP1-related tumor predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS527435707 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS527439925 |
KRIT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Angiokeratoma corporis diffusum with arteriovenous fistulas, Cerebral cavernous malformation |
| RS527441189 |
ELN
|
Health Risk |
Pathogenic/Likely pathogenic |
Supravalvar aortic stenosis, Supravalvar aortic stenosis |
| RS527442928 |
METTL23
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal recessive 44 |
| RS527449526 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS527451635 |
PRCD
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinitis pigmentosa 36 |
| RS527454830 |
RECQL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Baller-Gerold syndrome, Ovarian cancer |
| RS527462024 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS527467559 |
BLTP1
|
Health Risk |
Likely pathogenic |
Alkuraya-Kucinskas syndrome, Alkuraya-Kucinskas syndrome |
| RS527471560 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS527488103 |
GNAS
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, 8 conditions |
| RS527488398 |
ARHGEF10
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS527492258 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Inborn genetic diseases |
| RS527501342 |
FAT3
|
Health Risk |
Conflicting classifications of pathogenicity |
FAT3-related disorder, FAT3-related disorder |
| RS527501404 |
KMT2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS527503775 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial melanoma |
| RS527505920 |
CACNA1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperaldosteronism, familial |
| RS527512369 |
RAI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, RAI1-related disorder |
| RS527513599 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS527516269 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Inborn genetic diseases |